Secondary prophylaxis therapy: what are the benefits, limitations and unknowns?
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D005169:Factor VIII / Q000627:therapeutic use; D006395:Hemarthrosis / Q000209:etiology / Q000517:prevention & control*; D006467:Hemophilia A / Q000191:economics / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
D005169:Factor VIII